|

GnP Clinical Trials

2 actively recruiting trials across 1 location

No change since May 2026

Pipeline

Phase 3: 1Phase 2/3: 1

Top Sponsors

  • Kochi University1
  • Immuneering Corporation1

Indications

  • Pancreatic Adenocarcinoma2
  • Cancer2
  • PDAC1
  • Pancreatic Adenocarcinoma Metastatic1
  • Pancreatic Cancer Metastatic1

Other1 trial

Neoadjuvant Chemotherapy for Pancreatic Cancer Followed by GS and GnP
Phase 2/3

Phoenix, Arizona1 trial

Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma

City of Hope

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.